Are voiding symptoms associated with the survival outcome of primary female urethral cancer?
Issued Date
2025-01-01
Resource Type
eISSN
20388314
Scopus ID
2-s2.0-105024314192
Journal Title
Urogynaecologia International Journal
Volume
37
Rights Holder(s)
SCOPUS
Bibliographic Citation
Urogynaecologia International Journal Vol.37 (2025)
Suggested Citation
Laksanabunsong P., Jongjitaree K., Ramart P. Are voiding symptoms associated with the survival outcome of primary female urethral cancer?. Urogynaecologia International Journal Vol.37 (2025). doi:10.4081/uij.2025.348 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/113572
Title
Are voiding symptoms associated with the survival outcome of primary female urethral cancer?
Author(s)
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
Primary female urethral cancer (PFUC) is a rare urologic malignancy. Some patients who primarily presented with voiding symptoms experienced delayed investigation due to a lack of awareness. Therefore, this retrospective study aimed to compare the clinical information, treatment, and survival outcomes of PFUC between patients who initially presented with voiding symptoms and those with other symptoms. We retrospectively reviewed 13 PFUC patients who were treated at our hospital between January 2010 and December 2023. The overall 2-year survival rate was 55.4%. Factors including high-risk tumor, R1 resection, adenocarcinoma pathology, and nodal metastasis showed statistically significant differences between survival curves. The 2-year survival rates for patients with voiding symptoms and other symptoms were 34.3% and 80%, respectively. Although the overall survival rates between the two groups were not significantly different, PFUC patients with voiding symptoms demonstrated characteristics of advanced disease, including larger tumor size and nodal metastasis.